Affiliation:
1. School of Pharmaceutical Sciences and Institute of Materia Medica, Xinjiang University, Urumqi 830017, China
2. College of Life Science and Technology, Xinjiang University, Urumqi 830000, China
Abstract
Photothermal therapy (PTT) is a promising cancer therapy modality with significant advantages such as precise targeting, convenient drug delivery, better efficacy, and minimal adverse effects. Photothermal therapy effectively absorbs the photothermal transducers in the near-infrared region (NIR), which induces the photothermal effect to work. Although PTT has a better role in tumor therapy, it also suffers from low photothermal conversion efficiency, biosafety, and incomplete tumor elimination. Therefore, the use of nanomaterials themselves as photosensitizers, the targeted modification of nanomaterials to improve targeting efficiency, or the combined use of nanomaterials with other therapies can improve the therapeutic effects and reduce side effects. Notably, noble metal nanomaterials have attracted much attention in PTT because they have strong surface plasmon resonance and an effective absorbance light at specific near-infrared wavelengths. Therefore, they can be used as excellent photosensitizers to mediate photothermal conversion and improve its efficiency. This paper provides a comprehensive review of the key role played by noble metal nanomaterials in tumor photothermal therapy. It also describes the major challenges encountered during the implementation of photothermal therapy.
Funder
Key Research and Development Program in the Xinjiang Uygur Autonomous Region
Tianshan Talent Training Program
Autonomous Region Universities’ Basic Research Funds, Research Projects—Cultivation Projects
Xinjiang Uygur Autonomous Region Tianchi Talent Introduction Program—Young Doctor
Reference104 articles.
1. Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines;Kamineni;Ann. Intern. Med.,2022
2. Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Bray;CA A Cancer J. Clin.,2024
3. Agatha, C.M., Wijovi, F., Putri, H., and Kurniawan, A. (2018). Risk of Sarcopenia as the Side Effect of Chemotherapy among Breast Cancer Patients: Preliminary Study. Ann. Oncol., 29.
4. Red Blood Cell-Facilitated Photodynamic Therapy for Cancer Treatment;Tang;Adv. Funct. Mater.,2016
5. Tumor Microenvironment-Sensitive Ca2+ Nanomodulator Combined with the Sonodynamic Process for Enhanced Cancer Therapy;Yu;ACS Appl. Mater. Interfaces,2024
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献